Company Reaches $479 Million Settlement Over Defects in CPAP Machines
Medically reviewed by Drugs.com.
By Cara Murez HealthDay Reporter
FRIDAY, Sept. 8, 2023 -- Philips Respironics has agreed to a partial $479 million settlement to users of CPAP machines that blew gases and flecks of foam into their mouths and lungs.
Class action lawsuits against the company are ongoing, the New York Times reported.
This agreement is only for monetary reimbursements to device users and vendors who paid for replacement machines. It does not have a cap, which will allow other device users to apply for compensation, the Times reported.
The federal court must still approve the settlement, and Philips did not admit wrongdoing or liability, the Times reported.
“We are confident in these claims and we look forward to holding Philips accountable for the physical harms they caused patients,” the plaintiffs’ lawyers said in a statement.
The machines were recalled in June 2021 by the Food and Drug Administration. The recall also covered BiPAP devices and ventilators made since 2009.
The FDA has said the company should have notified consumers about flaws earlier. Concerns at the company began in 2015, the Times reported.
In the recall notice, the FDA warned that the products could cause “serious injury” to users because of the foam deterioration.
“Patient safety and quality are our top priorities, and we want patients to feel confident when using their Philips Respironics devices,” the company said in a statement.
The company has recalled about 5 million breathing machines. The defects were linked to health issues including respiratory illnesses, lung cancer and death. The machines may have been involved in 105,000 injuries and 385 deaths, the Times reported.
Sleep apnea affects millions of people. It is associated with increased risks of strokes, heart attacks and thinking declines.
As part of Thursday’s agreement, plaintiffs would each receive between about $50 and $1,500, plus $100 for each device returned to Philips, which has replaced nearly 2.5 million devices.
Sources
- New York Times
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
San Francisco Set to Ban 'Forever Chemicals' in Firefighter Gear
TUESDAY, May 14, 2024 -- San Francisco is on the verge of passing a ban on "forever chemicals" in the protective clothing firefighters wear while battling blazes. City lawmakers...
Police Seizures of Pills With Fentanyl Have Skyrocketed
MONDAY, May 13, 2024 -- Police seizures of illicit fentanyl pills have soared in recent years, a new study has found. The number of pills containing fentanyl seized by law...
Big Rise in Emergencies Involving Synthetic Weed Among Kids, Adults
WEDNESDAY, May 8, 2024 -- Calls to U.S. poison centers regarding so-called synthetic cannabis jumped 88% between 2021 and 2022, as use of these legally sold products rose...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
